Brian Gormley
Reporter, The Wall Street Journal.
Brian Gormley is a Special Writer covering life sciences for Dow Jones VentureWire. He joined Dow Jones in 2004.
• Invalid email address.
• You can't enter more than 20 emails.
• Seperate multiple addresses with Commas.
• Must enter an email address.
• You must enter the verification code below to send.
• Invalid entry: Please type the verification code again.
Articles by Brian Gormley
-
Subscriber Content Read Preview
Heal Raises $38.5M Series A for Doctor House Calls
October 18, 2016 12:01 a.m.Tull Investment Group led the round, which included Breyer Capital, Hashtag One, March Capital Partners, Slow Ventures and Qualcomm Inc. Executive Chairman Paul Jacobs. Heal has raised $43.5 million in seed and Series A funding.
-
Subscriber Content Read Preview
Enable Injections Closes $30M Financing Led by ORI Healthcare Fund
October 5, 2016 06:33 p.m.Enable Injections Inc., which has developed a wearable product for injecting biological drugs, said it has closed a $30 million Series A round led by ORI Healthcare Fund.
-
VCs See Potential in the Microbiome
September 18, 2016 10:01 p.m.Venture capital floods into companies trying to use microbiome science to achieve breakthroughs in medicine, agriculture and other fields.
-
Subscriber Content Read Preview
Chrono Therapeutics Raises $47.6M Series B for Smoking-Cessation Tech
September 8, 2016 03:28 p.m.Venture investors are betting that a digital smoking-cessation system will help smokers who have tried everything to finally quit.
-
Subscriber Content Read Preview
Investor Larry Bock Helped Launch Dozens of Biotechs
July 15, 2016 11:51 a.m.Larry Bock became a leading biotechnology investor and entrepreneur. He also founded the USA Science and Engineering Festival, a circus-like event to inspire young people to explore careers in those fields. He died July 6 of pancreatic cancer at 56.
-
Subscriber Content Read Preview
Gormley’s Take: Road to Launching ‘Biosimilar’ Drugs Just Got Longer
July 13, 2016 07:30 a.m.Small companies developing lower-cost copies of expensive biotechnology drugs already faced a tough road launching their products. A new court ruling could make that journey even tougher, and longer.
-
Subscriber Content Read Preview
OrbiMed Closes Second Israel Venture Fund at $307M
May 23, 2016 01:08 p.m.OrbiMed Advisors, which sold Israeli holding cCAM Biotherapeutics to Merck & Co. last year for $605 million, will use the vehicle to make early- to later-stage investments in drug, diagnostic, medical-device and digital-health businesses.
-
Oscar Insurance Valued at $2.7B After $400 Million Stake Led by Fidelity
February 24, 2016 07:20 p.m. -
Subscriber Content Read Preview
Venture Capitalists Invest $75M to Launch Forty Seven
February 24, 2016 04:09 p.m.Venture capitalists are investing $75 million to launch Forty Seven Inc., a startup out of Stanford University that has joined a race to defeat cancer by engaging the immune system in the fight against tumors.
-
Subscriber Content Read Preview
Agilent Sues Start-Up Over Trade Secrets
February 4, 2016 11:51 a.m.Agilent is suing Twist Bioscience, alleging that a former employee is using trade secrets and confidential information, according to complaint filed Wednesday.
-
Metabiota Turns to Genomics Pioneer for Help Preventing Epidemics
December 21, 2015 12:01 p.m. -
Subscriber Content Read Preview
McKesson Ventures Bets on Emerging Home-Care Market
November 20, 2015 05:54 p.m. -
Subscriber Content Read Preview
5 Trends in Health Care Venture Investment in 2015
August 12, 2015 09:34 a.m.Dow Jones analyzed U.S. health-care venture capital investment across 17 areas of the human body to determine which markets are attracting the most interest.
-
Subscriber Content Read Preview
ProNAi, Chiasma Shares Rise Quickly Following IPOs
July 16, 2015 01:14 p.m.Shares of ProNAi Therapeutics and Chiasma rose quickly following the companies’ initial public offerings Thursday, continuing a solid run of new offerings from venture-backed life sciences companies.
-
Health-Care Crossover Investors Lead Way in Second-Quarter IPOs
July 9, 2015 01:53 p.m. -
Subscriber Content Read Preview
Health-Care Startups Raise Record Venture Capital
April 21, 2015 12:28 p.m.U.S. medical startups raised a record $3.9 billion in venture capital in the first quarter of 2015 amid rising investor interest in biotechnology, digital health and health-care services.
-
Subscriber Content Read Preview
Nabriva Therapeutics Amasses $120M for Drug to Treat Bacterial Pneumonia
April 8, 2015 06:47 p.m.Nabriva’s drug candidate attacks bacteria’s ribosome, their protein-making machinery.
-
Subscriber Content Read Preview
Kleiner Perkins Leads $20M Round in Livongo for Cloud-Enabled Glucose Meter
April 7, 2015 09:02 a.m.Livongo’s system includes a glucose meter that transmits data to the cloud where they can be analyzed and monitored by the company’s diabetes educators.
-
Joel Marcus of Alexandria Real Estate on the Biotech Boom
March 30, 2015 01:54 p.m. -
Subscriber Content Read Preview
Ginkgo Bioworks Raises $9M to ‘Engineer’ Food Flavors, Fragrances
March 18, 2015 03:37 p.m.Ginkgo genetically programs microbes to produce molecules used in flavors, fragrances, cosmetics and nutritional ingredients.
Popular Now
What's This?
Close
Content engaging our readers now, with additional prominence accorded if the story is rapidly gaining attention. Our WSJ algorithm comprises 30% page views, 20% Facebook, 20% Twitter, 20% email shares and 10% comments.
Content engaging our readers now, with additional prominence accorded if the story is rapidly gaining attention. Our WSJ algorithm comprises 30% page views, 20% Facebook, 20% Twitter, 20% email shares and 10% comments.
See any information that needs updating on this Topic page?
Let us know »